SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 220 filers reported holding SAGE THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.84 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $772,297 | -8.7% | 20,249 | -6.2% | 0.02% | -26.7% |
| Q3 2022 | $846,000 | +201.1% | 21,594 | +227.2% | 0.03% | +76.5% |
| Q4 2021 | $281,000 | -60.7% | 6,599 | -73.5% | 0.02% | -67.3% |
| Q1 2020 | $715,000 | +245.4% | 24,897 | +1050.5% | 0.05% | +300.0% |
| Q4 2018 | $207,000 | -58.4% | 2,164 | -38.6% | 0.01% | -64.9% |
| Q3 2018 | $498,000 | -84.3% | 3,523 | -82.6% | 0.04% | -83.1% |
| Q2 2018 | $3,163,000 | +628.8% | 20,205 | +230.8% | 0.22% | +291.1% |
| Q1 2017 | $434,000 | -14.1% | 6,108 | -38.3% | 0.06% | -30.0% |
| Q4 2016 | $505,000 | -38.4% | 9,900 | -44.4% | 0.08% | -56.3% |
| Q3 2016 | $820,000 | -36.7% | 17,800 | -31.0% | 0.18% | +38.6% |
| Q1 2015 | $1,296,000 | – | 25,815 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 475,600 | $15,362,000 | 5.31% |
| Integral Health Asset Management, LLC | 412,257 | $13,316,000 | 2.74% |
| Palo Alto Investors LP | 851,409 | $27,501,000 | 2.40% |
| Boxer Capital, LLC | 1,094,000 | $35,336,000 | 2.24% |
| DAFNA Capital Management LLC | 180,306 | $5,824,000 | 1.59% |
| Ikarian Capital, LLC | 250,000 | $8,075,000 | 1.47% |
| Bellevue Group AG | 2,973,178 | $96,034,000 | 1.36% |
| SECTOR GAMMA AS | 118,476 | $3,827,000 | 0.86% |
| Artal Group S.A. | 450,000 | $14,535,000 | 0.78% |
| Diametric Capital, LP | 19,393 | $626,000 | 0.46% |